Article info

Original research
Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma

Authors

  1. Correspondence to Dr Raja Rajalingam; rajalingam.raja{at}ucsf.edu
View Full Text

Citation

Sun H, Martin TG, Marra J, et al
Individualized genetic makeup that controls natural killer cell function influences the efficacy of isatuximab immunotherapy in patients with multiple myeloma

Publication history

  • Accepted June 7, 2021
  • First published July 16, 2021.
Online issue publication 
July 16, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.